Ed Tucker, M.D.
Ed Tucker, M.D., is chief medical officer at Mirum. In this role, he oversees clinical development, safety science and operations to advance our development pipeline. Prior to joining Mirum, Dr. Tucker served as chief operating officer at Acerta Pharma LLC where he supported the first U.S. approval and launch of Calquence in 2017. Prior to joining Acerta, Dr. Tucker held leadership positions in clinical development, medical safety, and medical affairs at Bayer AG, Janssen Pharmaceutica, and Genentech, Inc. He held several medical posts with the National Health Service in the United Kingdom from 1996 to 2000. Dr. Tucker is a member of the Royal College of Physicians (U.K.) and received an M.B.A. from the University of Connecticut and has degrees in pharmacology and medicine from the University of Leeds, United Kingdom.